INTRODUCTION
Taxol™, a diterpene purified from the bark of the Western yew (Taxus brevifolia), 1 is an antitumor agent that blocks mitosis by binding and stabilizing microtubules. 2, 3 Although the structure of Taxol™ is quite different from that of the LPS lipid A moiety ( Fig. 1) , which is responsible for many LPS responses, 4 Taxol™ has been shown to exhibit many LPS-mimetic activities in murine macrophages, such as induction of tumor necrosis factor secretion, 5 nitric oxide production, 6 and NF-kB activation. 7 Taxol™ was suggested to share a receptor and/or signaling molecule with LPS because these LPS-mimetic activities of Taxol™ were not detected in macrophages from LPS-hyporesponsive C3H/HeJ mice. [5] [6] [7] Interestingly, the LPS-mimetic activities of Taxol™ were species-specific: Taxol™ did not mimic the action of LPS on human LPS-responsive cells including macrophages. 8, 9 By using stable transfectants expressing MD-2 and/or TLR4, we found that mouse TLR4/MD-2 mediates LPS-mimetic signal transduction by Taxol™, and that the species-specific LPS-mimetic action of Taxol™ was based on the species-difference between mouse and human TLR4/MD-2. 10 In this study, we investigated the molecular basis for the species-specific LPS-mimetic action of Taxol™, and found that Gln-22 of mouse MD-2 is essential for LPS-mimetic Taxol™ signaling, but not for LPS signaling.
Flavolipin is an amino acid-containing lipid (Fig. 1 ). 11, 12 Amino acid-containing lipids, including ornithine-containing and glycine-containing lipids, are present in many Gram-negative bacteria, such as Bordetella pertussis, 13 Pseudomonas aeruginosa, 14 Achromobacter xylosoxidans, 15 and Cytophaga johnsonae. 16 Flavolipin, which contains serine and glycine, is unique to Flavobacterium spp., and comprises about 20% of the cellular lipids of Flavobacterium meningosepticum. 11, 17 Flavolipin has been shown to induce inflammatory immune responses, such as PGE 2 , IL-1b and TNF-a production by macrophages. 18 The cellular receptor and signaling molecules for flavolipin have not been characterized well, and the essential moiety of flavolipin for the induction of an immune response has not been determined yet. The signaling
We previously reported that Taxol™, which mimics the action of LPS on murine macrophages, induces signals via mouse TLR4/MD-2, but not via human TLR4/MD-2. Here we investigated the molecular basis for this species-specific action of Taxol™. Expression of mouse MD-2 conferred both LPS and Taxol™ responsiveness on HEK293 cells expressing mouse TLR4, whereas expression of human MD-2 conferred LPS responsiveness alone, suggesting that MD-2 is responsible for the species-specificity of Taxol™ responsiveness. Furthermore, mouse MD-2 mutants, in which Gln-22 was changed to other amino acids, showed dramatically reduced ability to confer Taxol™ responsiveness, although their ability to confer LPS responsiveness was not affected. These results indicated that Gln-22 of mouse MD-2 is essential for Taxol™ signaling, but not for LPS signaling. In this study, we also found that the TLR4/MD-2 complex, together with CD14, mediated signal transduction induced by flavolipin, an amino acid-containing lipid unique to Flavobacterium meningosepticum. events by which flavolipin induces the production of inflammatory cytokines are suggested to be shared, at least in part, by that of LPS because flavolipin does not induce cytokine production by macrophages derived from LPShyporesponsive C3H/HeJ mice. 18 In this study, we show that the flavolipin signal is mediated by the TLR4/MD-2 complex. In addition, we show that the (R)-configuration of the lipid moiety in flavolipin is essential for induction of the signals mediated by the TLR4/MD-2 complex.
MATERIALS AND METHODS

Reagents
Taxol™ from T. brevifolia was purchased from Sigma (St Louis, MO, USA). LPS prepared from Escherichia coli O111:B4 was purchased from List Biological Laboratories (Campbell, CA, USA). Flavolipin was prepared from F. meningosepticum by the method reported previously 11 with slight modifications. Flavolipin stereo-isomers, N-(S or R)- 
cDNAs and expression constructs
Human or mouse MD-2 cDNA was cloned into the XhoI and NotI sites of an expression vector, pEFBOS, 19 by PCR-based introduction of restriction sites. Human/mouse chimeric MD-2 cDNAs and mutant MD-2 cDNAs were generated by PCR-based overlap extension. 20 The sequences of the PCR primers are shown in Table 1 . Recombinant human or mouse MD-2 expression constructs 10 or cMD2-1 (see below) were used as PCR template. Chimeric MD-2 cDNAs and mutant MD-2 cDNAs were cloned into the XhoI and NotI sites of pEFBOS. The inserts of the expression constructs were verified by sequencing with an ABI PRISM™ Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). The stuffer region of pEFBOS was eliminated by digestion with XbaI, and the resulting construct was named pEFBOS(-).
Luciferase assay
Luciferase activity in cell lysates was measured with a luciferase assay system (Promega, Tokyo, Japan) as described previously. 10
RESULTS AND DISCUSSION
Mouse MD-2 is essential for species-specific lipopolysaccharide-mimetic action of Taxol™
We have previously shown that the species specificity of Taxol™-responsiveness can be ascribed to a difference in the TLR4/MD-2 complex between mouse and human. 10 To examine if the MD-2 molecule is involved in ligand discrimination, we made HEK293 transfectant cells expressing mouse TLR4 and mouse MD-2 or human MD-2. As shown in Figure 2 , 293/mTLR4/luc cells expressing mouse MD-2 responded well to both Taxol™ and LPS stimulation, but 293/mTLR4/luc cells expressing human MD-2 responded to LPS stimulation but not to Taxol™ stimulation. These results shows that human MD-2 does not have the ability to confer Taxol™ responsiveness on mouse TLR4, although it has the ability to confer LPS responsiveness on mouse TLR4, suggesting that MD-2 is involved in ligand discrimination.
The amino acid sequence encoded by mouse MD-2 cDNA exhibited 64% identity with that encoded by human MD-2 cDNA. 21 To understand the molecular basis of the ligand discrimination by MD-2, constructs expressing mouse/human chimeric MD-2 proteins were generated ( Fig. 3) , and their ability to confer Taxol™ responsiveness was examined. The 293/mTLR4/luc cells expressing cMD2-2, cMD2-3, cMD2-4, cMD2-5 or cMD2-6 did not respond to Taxol™ stimulation, and those expressing cMD2-1 slightly responded to Taxol™ stimulation ( Fig. 3 ). On the other hand, all of the transfectants expressing chimeric MD-2 proteins responded to LPS stimulation, although some transfectants, such as those expressing cMD2-4, cMD2-5, or cMD2-6, showed Molecular basis for lipopolysaccharide mimetic action of Taxol™ and flavolipin 303 Fig. 2 . Human MD-2 confers LPS responsiveness, but not Taxol™ responsiveness, on mouse TLR4. HEK293 cells introduced with NF-kB dependent luciferase reporter construct (293/luc) and 293/luc cells stably expressing mouse TLR4 (293/mTLR4/luc) cells were transfected without (Control) or with an expression construct for mouse MD-2 (Mouse MD-2) or human MD-2 (Human MD-2). Three days after transfection, the cells were cultivated in medium containing 0.5% dimethylsulfoxide (Medium) or in medium containing 0.5% dimethylsulfoxide and 100 ng/ml LPS (LPS) or 10 mM Taxol™ (Taxol™) for 6 h, and then luciferase activity was measured. Luciferase activity was normalized as to the activity in the cells cultivated in the medium containing 0.5% dimethylsulfoxide, and are presented as fold induction. The bars indicate the averages for duplicate wells. The results shown are representative of three independent experiments. Table 1 . Primers used for construction of chimera or mutant MD-2 cDNAs Primer name Sequence (5¢®3¢) Generated chimera or mutant MD-2 cDNA hEF1a-S1 CTCCTTGGAATTTGCCCT cMD2-1, 2, 3, 4, 5, and 6, Y22Q-cMD2-1, P13S, S18A, E19Q, and Q22Y-mouse MD2 hMD2-A AGGAAAAAAGCGGCCGCCTAATTTGAATTAGGT cMD2-4, 5, and 6 mMD2-A AGGAAAAAAGCGGCCGCCTAATTGACATCACGG cMD2-1, 2, and 3, Y22Q-cMD2-1, P13S, S18A, E19Q, and Q22Y-mouse MD2 cMD2-1-
reduced sensitivity to LPS (Fig. 3 ). This reduced LPS sensitivity may suggest that the structures of these chimera constructs are different from those of human or mouse MD-2.
One of the chimeric MD-2s, named cMD2-1, constructed by replacing the N-terminal 24 amino acids of mouse MD-2 with that of human MD-2, responded to LPS stimulation but only slightly responded to Taxol™ stimulation. Because only nine amino acid residues were different between the amino acid sequences of mouse MD-2 and cMD2-1 (Figs 3 & 4) , we next determined which of the nine different amino acid residues were important for Taxol™ signaling, by generating mutant mouse MD-2 expression constructs in which Pro-13, Ser-18, Glu-19 or Gln-22 was replaced with the corresponding amino acid residue of human MD-2, and then examining their ability to confer Taxol™ and LPS responsiveness ( Fig.  4) . Although P13S-, S18A-and E19Q-mouse MD-2 exhibited similar abilities to confer Taxol™ responsiveness on 293/mTLR4/luc cells to that of mouse MD-2, Q22Y-mouse MD-2 had an apparently lower ability to confer Taxol™ responsiveness than mouse MD-2 (Fig. 4B ). Furthermore, the cells expressing Y22Q-cMD2-1, in which Tyr-22 of cMD2-1 was replaced with mouse type Gln-22, showed similar sensitivity to Taxol™ to that of the cells expressing mouse MD-2 (Fig. 4C ). On the other hand, the sensitivity to LPS was similar between the cells expressing mouse MD-2 and those expressing Q22Y-mouse MD-2 (Fig. 4A) . These results, taken together, indicate that Gln-22 of mouse MD-2 is involved in the species-specific LPS-mimetic action of Taxol™.
The TLR4/MD-2 complex mediates signal transduction induced by flavolipin
Genetic characterization of C3H/HeJ mice suggested that a point mutation in TLR4 affects flavolipin responsiveness in the mice. 18 It has remained undetermined if TLR4 directly mediates flavolipin-induced signaling, and if MD-2, which associates with the extracellular portion of TLR4, is involved in the signaling.
To determine whether or not TLR4 or the TLR4/MD-2 complex mediates flavolipin signaling, we examined flavolipin responsiveness by measuring NF-kB activation in a Ba/F3 stable transfectant expressing mouse TLR4, named Ba/mTLR4, and a Ba/F3 stable transfectant expressing both mouse TLR4 and mouse MD-2, named Ba/mTLR4/mMD2, by EMSA. As shown in Figure 5 , flavolipin evidently induced NF-kB activation in Ba/mTLR4/mMD2 cells. On the other hand, under the same conditions, it did not induce NF-kB activation in Ba/F3 or Ba/mTLR4 cells. Similar results were obtained with LPS or Taxol™ stimulation. Furthermore, we measured NF-kB activation by means of flavolipin stimulation in a Ba/F3 stable transfectant expressing both MD-2 and mutant TLR4 lacking the cytoplasmic portion, named Ba/mTLR4D/mMD2. As shown in Figure 5 , flavolipin did not induce NF-kB activation in Ba/mTLR4D/ mMD2 cells, implying that the cytoplasmic portion of TLR4 is required for flavolipin signaling. These results, taken together, demonstrate that co-expression of TLR4 and MD-2 confers flavolipin responsiveness on Ba/F3 cells. To determine whether or not CD14 contributes to the flavolipin signaling via the TLR4/MD-2 complex, we compared the flavolipin responsiveness of Ba/mTLR4/mMD2 cells with that of Ba/mTLR4/mMD2 cells stably expressing mouse CD14 (Ba/mTLR4/mMD2/CD14). As shown in Figure 6 , flavolipin-induced NF-kB activation in Ba/mTLR4/mMD2/CD14 cells was apparently higher than that in Ba/mTLR4/mMD2 cells. These results suggest that CD14 is involved in the signaling events induced by flavolipin. Such an effect of CD14 has also been observed in the case of LPS-induced NF-kB activation (Fig. 6) . But in the case of Taxol™ signaling, expression of CD14 did not enhance NF-kB activation (Fig. 6 ). This result is consistent with the previous findings that like LPS, Taxol™ induces both CD14-dependent and -independent pathways for gene activation, although the CD14 dependency of Taxol™ stimulation is much less striking than that observed with LPS. 22 These results suggest that the requirement of CD14 expression for NF-kB activation differs among LPS, Taxol™, and flavolipin stimulation, although the requirement of the TLR4/MD-2 complex is the same among these stimuli.
In order to determine the essential moiety of flavolipin for the induction of immune responses, we chemically synthesized flavolipin stereo-isomers ( Fig. 7) . In addition to these flavolipin stereo-isomers, we also synthesized stereo-isomers of flavolipin analogs, (R or S)-lipid-(L or D)-Ser-Gly and (R or S)-lipid-(L or D)-Ser. We examined the ability of these flavolipin stereo-isomers and analogs to induce NF-kB activation via the TLR4/MD-2 complex. As or Gln-22 was changed to the corresponding amino acid residue of human MD-2 were generated, the mutant mouse MD-2 proteins being named P13S, S18A, E19Q and Q22Y, respectively. 293/mTLR4/luc cells were transfected without (Control) or with an expression construct for mouse MD-2 (Mouse MD-2) or mutant mouse MD-2 proteins (P13S, S18A, E19Q and Q22Y). Luciferase activity was measured and presented as in Figure 2 . The bars indicate the averages for duplicate wells. The results shown are representative of two independent experiments. (C) 293/mTLR4/luc cells were transfected without (Control) or with an expression construct for mouse MD-2, human MD-2, cMD2-1, Q22Y-mouse MD-2 or Y22Q-cMD2-1 that encodes a mutant cMD2-1 protein in which Tyr-22 was changed to Gln. Three days after transfection, the cells were cultivated in medium containing 0.5% dimethylsulfoxide and the indicated amount of Taxol™ for 6 h, and then luciferase activity was measured. The results shown are the averages for duplicate wells. Ba/F3, Ba/mTLR4, Ba/mTLR4/mMD2, or Ba/mTLR4D/mMD2 cells 10 were incubated at 37°C for 1 h in culture medium containing 0.001% TEA and 0.0025% DOC (lanes 1, 5, 9, and 13), 100 mg/ml flavolipin, 0.001% TEA, and 0.0025% DOC (lanes 2, 6, 10, and 14), 5 ng/ml LPS (lanes 3, 7, 11, and 15 ), or 10 mM Taxol™ (lanes 4, 8, 12, and 16 ). After incubation, nuclear extracts were prepared and subjected to EMSA to measure NF-kB activation.
shown in Figure 7 , (R)-flavolipin, in which the stereochemistry of the lipid moiety is R, and (R)-analogs induced NF-kB activation in the cells expressing TLR4 and MD-2, but (S)-flavolipin and (S)-analogs did not. On the other hand, the configuration at the serine residue and the amino acid sequence of the amino acid moiety did not affect the ability to induce NF-kB activation via the TLR4/MD-2 complex. These results demonstrate that the (R)-configuration of the flavolipin lipid moiety is important for the induction of signals via the TLR4/MD-2 complex, and that the configuration at the serine residue and the amino acid sequence of the amino acid moiety are not important for induction of the signaling. As for the structural requirement of flavolipin for its activity, similar results were obtained by using RAW264.7 and J774.1 cells (data not shown).
CONCLUSIONS
We have shown that flavolipin responsiveness was acquired through the co-expression of TLR4 and MD-2 on Ba/F3 cells. In addition, we have shown that expression of CD14 enhances flavolipin signaling mediated by the TLR4/MD-2 complex. Furthermore, we have demonstrated that the (R)-configuration of the lipid moiety of flavolipin is essential for the induction of the signaling mediated by the TLR4/MD-2 complex, and that the configuration at the serine residue and the amino acid sequence of the amino acid moiety are not important for induction of the signaling. Fig. 6 . Expression of CD14 enhances flavolipin signaling. Ba/mTLR4/mMD2 or Ba/mTLR4/mMD2/CD14 cells were stimulated with the indicated concentrations of flavolipin, LPS or Taxol™, and then NF-kB activation was measured by EMSA as described in the caption to Figure 5 . The results shown are representative of two independent experiments. 
